Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 5105108, 10 pages
http://dx.doi.org/10.1155/2016/5105108
Review Article

Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

1Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China
2Shanghai Public Health Clinical Center, Shanghai 201508, China

Received 20 December 2015; Revised 4 April 2016; Accepted 20 April 2016

Academic Editor: Jiande D. Z. Chen

Copyright © 2016 Bozong Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. J. Brandt, W. D. Chey, A. E. Foxx-Orenstein et al., “An evidence-based position statement on the management of irritable bowel syndrome,” American Journal of Gastroenterology, vol. 104, supplement 1, pp. S1–S35, 2009. View at Google Scholar
  2. E. Rey and N. J. Talley, “Irritable bowel syndrome: novel views on the epidemiology and potential risk factors,” Digestive and Liver Disease, vol. 41, no. 11, pp. 772–780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. P. S. Hungin, L. Chang, G. R. Locke, E. H. Dennis, and V. Barghout, “Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact,” Alimentary Pharmacology & Therapeutics, vol. 21, no. 11, pp. 1365–1375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. A. Drossman, C. B. Morris, S. Schneck et al., “International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit,” Journal of Clinical Gastroenterology, vol. 43, no. 6, pp. 541–550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Ringel, R. E. Williams, L. Kalilani, and S. F. Cook, “Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome,” Clinical Gastroenterology and Hepatology, vol. 7, no. 1, pp. 68–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Inadomi, M. B. Fennerty, and D. Bjorkman, “Systematic review: the economic impact of irritable bowel syndrome,” Alimentary Pharmacology Therapeutics, vol. 18, no. 7, pp. 671–682, 2003. View at Google Scholar
  7. L. V. McFarland, “State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008,” World Journal of Gastroenterology, vol. 14, no. 17, pp. 2625–2629, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Carmona-Sánchez and F. A. Tostado-Fernández, “Prevalence of use of alternative and complementary medicine in patients with irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease,” Revista de gastroenterología de México, vol. 70, no. 4, pp. 393–398, 2005. View at Google Scholar · View at Scopus
  9. S. Magge and A. Lembo, “Complementary and alternative medicine for the irritable bowel syndrome,” Gastroenterology Clinics of North America, vol. 40, no. 1, pp. 245–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Yoon, O. Grundmann, L. Koepp, and L. Farrell, “Management of irritable bowel syndrome (IBS) in adults: conventional and complementary/alternative approaches,” Alternative Medicine Review, vol. 16, no. 2, pp. 134–151, 2011. View at Google Scholar · View at Scopus
  11. D. Hu, M. Kang, J. Xiong, and P. Deng, “Irritable bowel syndrome with diarrhea (IBS-D) treated with moxibustion on heat-sensitive acupoints: a randomized controlled trial,” World Journal of Acupuncture—Moxibustion, vol. 22, no. 2, pp. 1–5, 2012. View at Publisher · View at Google Scholar
  12. Y. Y. Ni and J. Q. Lu, “Clinical research on moxibustion treatment of diarrhea type irritable bowel syndrome,” World Journal of Acupuncture-Moxibustion, vol. 11, no. 3, pp. 19–23, 2001. View at Google Scholar
  13. J.-W. Park, B.-H. Lee, and H. Lee, “Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis,” BMC Complementary and Alternative Medicine, vol. 13, article 247, pp. 1–14, 2013. View at Publisher · View at Google Scholar
  14. D. Hu, M. Kang, J. Xiong et al., “Irritable bowel syndrome with diarrhea (IBS-D) treated with moxibustion on heat-sensitive acupoints: a randomized controlled trial,” World Journal of Acupuncture-Moxibustion, vol. 22, no. 2, pp. 1–5, 2012. View at Google Scholar
  15. S. J. Luo, J. H. Long, and L. Huang, “The curative effect observation and nursing of moxibustion combined with pinaverium bromide tablets to cure abdominal pain and diarrhea intestine irritable syndrome,” Journal of Jinggangshan Medical College, vol. 15, no. 4, pp. 39–40, 2008. View at Google Scholar
  16. Y. B. Zhang, C. Y. Yan, and S. Xie, “Thirty cases of diarrhea-predominant irritable bowel syndrome treated by ginger-partitioned moxibustion,” Jiangxi Journal of Traditional Chinese Medicine, vol. 38, no. 296, pp. 69–70, 2007. View at Google Scholar
  17. G. D. Jin, “The efficiency observation of tianjiu therapy on irritable bowel syndrome of diarrhea type,” Journal of Zhejiang College of Traditional Chinese Medicine, vol. 33, no. 3, pp. 415–416, 2009. View at Google Scholar
  18. C. Sheng, D. Dongqing, Y. Ma, Z. Wang, S. Gao, and X. Wang, “clinical study on herbal cone-partitioned moxibustion for irritable bowel syndrome due to spleen-qi deficiency,” Journal of Acupuncture and Tuina Science, vol. 9, no. 5, pp. 265–268, 2011. View at Google Scholar
  19. H. Chu, X. Huang, X. Li, H. Chen, and Y. Ding, “Moxibustion for diarrhea-type irritable bowel syndrome: a clinical study,” Journal of Anhui TCM College, vol. 30, no. 6, pp. 33–36, 2011. View at Google Scholar
  20. S. X. Chen and Y. W. Wang, “Thirty two cases of diarrhea-predominant irritable bowel syndrome treated by heat-sensitive moxibustion,” Zhejiang Journal of Traditional Chinese Medicine, vol. 48, no. 3, pp. 199–120, 2013. View at Google Scholar
  21. Y.-X. Ma, X. Liu, C.-Z. Liu et al., “Randomized clinical trial: the clinical effects of herb-partitioned moxibustion in patients with diarrhoea-predominant irritable bowel syndrome,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 605460, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. P. T. Higgins and S. Green, Eds., Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0, The Cochrane Collaboration, 2011, http://handbook.cochrane.org.
  23. J. Luo and W. D. Leng, Eds., Theory & Practice of Systematic Review/Meta-Analysis, Military Medical Science Press, Beijing, China, 2013.
  24. J. P. T. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. B. D. Cash and W. D. Chey, “Diagnosis of irritable bowel syndrome,” Gastroenterology Clinics of North America, vol. 34, no. 2, pp. 205–220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. D. A. Drossman and D. L. Dumitrascu, “Rome III: new standard for functional gastrointestinal disorders,” Journal of Gastrointestinal and Liver Diseases, vol. 15, no. 3, pp. 237–241, 2006. View at Google Scholar · View at Scopus
  27. S. Q. Zhou and D. G. Li, “The epidemic survey of Fujian teenagers with irritable bowel syndrome,” Chinese Journal of Digestive Diseases, vol. 27, no. 3, pp. 169–173, 2007 (Chinese). View at Google Scholar
  28. G. F. Longstreth, W. G. Thompson, W. D. Chey, L. A. Houghton, F. Mearin, and R. C. Spiller, “Functional bowel disorders,” Gastroenterology, vol. 130, no. 5, pp. 1480–1491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. A. W. Bundeff and C. B. Woodis, “Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome,” Annals of Pharmacotherapy, vol. 48, no. 6, pp. 777–784, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Zakko, G. Barton, E. Weber, C. Dunger-Baldauf, and A. Rühl, “Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 33, no. 12, pp. 1311–1321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Ortiz-Lucas, A. Tobías, P. Saz, and J. J. Sebastián, “Effect of probiotic species on irritable bowel syndrome symptoms: a bring up to date meta-analysis,” Revista Espanola de Enfermedades Digestivas, vol. 105, no. 1, pp. 19–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Rezaie, S. Nikfar, and M. Abdollahi, “The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis,” Archives of Medical Science, vol. 6, no. 1, pp. 49–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. D. Dorn, T. J. Kaptchuk, J. B. Park et al., “A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome,” Neurogastroenterology and Motility, vol. 19, no. 8, pp. 630–637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Qi, H.-R. Liu, T. Yi et al., “Warming moxibustion relieves chronic visceral hyperalgesia in rats: relations to spinal dynorphin and orphanin-FQ system,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 920675, 10 pages, 2013. View at Publisher · View at Google Scholar
  35. E.-H. Zhou, X.-M. Wang, G.-H. Ding et al., “Suspended moxibustion relieves chronic visceral hyperalgesia and decreases hypothalamic corticotropin-releasing hormone levels,” World Journal of Gastroenterology, vol. 17, no. 5, pp. 662–665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Y. Wu, C. H. Bao, L. B. Ge et al., “Mild moxibustion at tianshu (ST 25) decreases expression of prokineticin-1 and prokineticin receptor-1 in colon tissue of rats with chronic visceral hyperalgesia,” Neural Regeneration Research, vol. 6, no. 33, pp. 2600–2604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. H. R. Liu, X. G. Hua, Y. Yang, and H. G. Wu, “Clinical study on 5-HT expression in colonic mucosa and the treatment of herb-partition moxibustion in diarrhea-predominant IBS,” Liaoning Zhongyi Zazhi, vol. 33, no. 8, pp. 984–985, 2006. View at Google Scholar
  38. Y. A. Saito, P. Schoenfeld, and G. R. Locke III, “The epidemiology of irritable bowel syndrome in North America: a systematic review,” The American Journal of Gastroenterology, vol. 97, no. 8, pp. 1910–1915, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. J.-W. Park, B.-H. Lee, and H. Lee, “Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis,” BMC Complementary and Alternative Medicine, vol. 13, article 247, 14 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. H. G. Wu, C. Zhao, Z. Shi, H. P. Chen, Y. Liu, and S. M. Liu, “Clinical study on spleen-stomach-reinforcing moxibustion treatment of diarrhea-type irritable bowel syndrome,” World Journal of Acupunct-Moxibust, vol. 12, no. 1, pp. 10–15, 2002. View at Google Scholar
  41. A. Wilson, G. F. Longstreth, K. Knight et al., “Quality of life in managed care patients with irritable bowel syndrome,” Managed Care Interface, vol. 17, no. 2, pp. 24–34, 2004. View at Google Scholar · View at Scopus
  42. J. M. Park, M.-G. Choi, Y. S. Kim et al., “Quality of life of patients with irritable bowel syndrome in Korea,” Quality of Life Research, vol. 18, no. 4, pp. 435–446, 2009. View at Publisher · View at Google Scholar · View at Scopus